Reverse Chemical Proteomics in Drug Discovery
Department of Chemistry & Biomolecular Sciences, Macquarie University, Sydney, NSW, 2109 Australia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 194; https://doi.org/10.3797/scipharm.oephg.21.SL-27
Submission received: 16 April 2009
/
Accepted: 16 April 2009
/
Published: 16 April 2009
Abstract
With advances in separation technology and structure elucidation, the main bottleneck limiting drug development from natural products is the identification of their cellular targets. Although effective therapeutic agents can be developed and successfully administered without knowledge of the underlying mechanism of action, elucidation of drug target proteins is essential in the design of new compounds with improved safety and efficacy [1].[...]
Share and Cite
MDPI and ACS Style
GOTSBACHER, M.; KARUSO, P. Reverse Chemical Proteomics in Drug Discovery. Sci. Pharm. 2009, 77, 194. https://doi.org/10.3797/scipharm.oephg.21.SL-27
AMA Style
GOTSBACHER M, KARUSO P. Reverse Chemical Proteomics in Drug Discovery. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):194. https://doi.org/10.3797/scipharm.oephg.21.SL-27
Chicago/Turabian StyleGOTSBACHER, M., and P. KARUSO. 2009. "Reverse Chemical Proteomics in Drug Discovery" Scientia Pharmaceutica 77, Short Lectures (SL): 194. https://doi.org/10.3797/scipharm.oephg.21.SL-27
